Virginia Retirement System’s Regeneron Pharmaceuticals REGN Stock Holding History

Virginia Retirement System’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$6.58M	Buy	+18,242	New	+$7.52M	0.1%	242

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Virginia Retirement System's REGN Position: Q1 2016 in Review

Virginia Retirement System opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2016: 18,242 shares worth $6.58M. The stake represents 0.1% of the portfolio and ranks #242 among its holdings.

549 funds tracked by Wall St. Rank hold REGN as of Q1 2016.

Virginia Retirement System held 18,242 shares of Regeneron Pharmaceuticals worth $6.58M as of Q1 2016.
Regeneron Pharmaceuticals was a new Virginia Retirement System position in Q1 2016.
Regeneron Pharmaceuticals made up 0.1% of Virginia Retirement System's portfolio in Q1 2016, its #242 holding.
549 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2016.

Based on Virginia Retirement System's 13F filing for Q1 2016, filed 29 Apr 2016.